Trastuzumab emtansine is the standard second-line treatment following horizontal blockade in first line of advanced HER-2 positive breast cancer: A plant that has still to grow. Issue 1 (2019)

Record Type:: Journal Article
Title:: Trastuzumab emtansine is the standard second-line treatment following horizontal blockade in first line of advanced HER-2 positive breast cancer: A plant that has still to grow. Issue 1 (2019)
Main Title:: Trastuzumab emtansine is the standard second-line treatment following horizontal blockade in first line of advanced HER-2 positive breast cancer: A plant that has still to grow
Authors:: Montella, Liliana
Prete, Salvatore Del
Bove, Pasquale
Is Part Of:: Integrative cancer science and therapeutics. Volume 6:Issue 1(2019)
Journal:: Integrative cancer science and therapeutics
Issue:: Volume 6:Issue 1(2019)
Issue Display:: Volume 6, Issue 1 (2019)
Year:: 2019
Volume:: 6
Issue:: 1
Issue Sort Value:: 2019-0006-0001-0000
Page Start:
Page End:
Publication Date:: 2019
Subjects:: Cancer -- Periodicals
Cancer -- Treatment -- Periodicals
616.99406
Journal URLs:: http://www.oatext.com/IntegrativeCancerScienceandTherapeutics.php#About_Journal ↗
DOI:: 10.15761/ICST.1000302 ↗
Languages:: English
ISSNs:: 2056-4546
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library HMNTS - ELD Digital store
Ingest File:: 14266.xml